NewAmsterdam Pharma N.V. (NAMS)
20.92
0.01 (0.05%)
At close: Feb 28, 2025, 3:59 PM
20.70
-1.05%
Pre-market: Mar 03, 2025, 04:06 AM EST
NewAmsterdam Pharma N.V. Revenue
NewAmsterdam Pharma N.V. reported an annual revenue of $12.76M, reflecting a -86.69% growth. For the quarter ending September 30, 2024, NewAmsterdam Pharma N.V. generated $29.11M in revenue.
Revenue (ttm)
$12.76M
Revenue Growth
-86.69%
Price / Sales Ratio
71.91
Revenue / Employee
$205.85K
Employees
62
Market Cap
2.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| 2023-12-31 | 12.76M | -86.69% |
| 2022-12-31 | 95.91M | +Infinity% |
| 2021-12-31 | 0 | n/a |
| 2020-12-31 | 0 | n/a |